E-Cadherin Expression in Thymomas

Yonsei Medical Journal

Volumn 39, Issue 1, 1998, Pages 37-44

  Yang, Woo Ick ^a   Yang, Kyung Moo ^b   Hong, Soon Won ^b   Kim, Kil Dong ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

E cadherin; Immunohistochemistry; Thymomas

Indexed keywords

CADHERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMISTRY; CLASSIFICATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; THYMOMA;

ADOLESCENT; ADULT; AGED; CADHERINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; THYMOMA; THYMUS NEOPLASMS;

EID: 0031989787     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1998.39.1.37     Document Type: Article

References (30)

1. Ashton-Key M, Cowley GP, Smith MEF: Cadherins in reactive lymph nodes and lymphomas: high expression in anaplastic large cell lymphomas. Histopathology 28: 55-59, 1996
2. Behrens J, Mareel MM, Van Roy FM, Birchmeier W: Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989
3. Birchmeir W, Weidner KM, Hulsken J, Behrens J: Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 4: 231-239, 1993
4. Brocheriou I, Carnot F, Briere J: Immunohistochemical detection of bcl-2 protein in thymoma. Histopathology 27: 251-255, 1995
5. Chan JKC, Tsang WYW, Seneviratne S, Pau MY: The MIC2 antibody O13. Practical application for the study of thymic epithelial tumors. Am J Surg Pathol 19: 1115-1123, 1995
6. Chen FF, Yan JJ, Jin YT, Su IJ: Detection of bcl-2 and p53 in thymoma: Expression of bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol 27: 1089-1092, 1996
7. Cowley GP, Smith ME: Cadherin expression in melanocytic naevi and malignant melanomas. J Pathol 179: 183-187, 1996
8. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189, 1996
9. Gumbiner BM: Cell adhesions; The molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996
10. Hayashi Y, Ishii N, Obayashi C, Jinnai K, Hanioka K, Imai Y, Itoh H: Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21. Virchows Arch 426: 43-50, 1995
11. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-446, 1996
12. Kirchner T, Müller-Hermelink HK: New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10: 167-189, 1989
13. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK: Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16: 1153-1169, 1992
14. Kuo TT, Lo SK: DNA flow cytometric study of thymic epithelial tumors with evaluation of its usefulness in the pathologic classification. Hum Pathol 24: 746-749, 1993
15. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF: Thymoma. A clinicopathologic review. Cancer 60: 2727-2743, 1987
16. Marino M, Müller-Hermelink HK: Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymoma. Virchows Arch (Pathol Anat) 407: 119-149, 1985
17. Masaoka A, Monden Y, Nakahara K, Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485-2492, 1981
18. Pescarmona E, Pisacane A, Rendina EA, Ricci C, Ruco LP, Baroni CD: 'Organoid' thymoma: a well-differentiated variant with distinctive clinicopathologic features. Histopathology 18: 161-164, 1991
19. Pescarmona E, Rendina EA, Venuta F, Ricci C, Ruco LP, Baroni CD: The prognostic implication of thymoma histologic subtype. A study of 80 consecutive cases. Am J Clin Pathol 93: 190-195, 1990
20. Pescarmona E, Rosati S, Pisacane A, Rendina EA, Venuta F, Baroni CD: Well-differentiated thymic carcinoma: a clinico-pathological study. Virchows Arch A Pathol Anat Histopathol 420: 179-183, 1992
21. Pich A, Chiarle R, Chiusa L, Ponti R, Geuna M, Casadio C, Maggi G, Palestro G: Long term survival of thymoma patients by histologic pattern and proliferative activity. Am J Sur Pathol 19: 918-926, 1995
22. Quintanilla-Martinez L, Müller-Hermelink HK, Wilkins EW Jr, Ferry JA, Harris NL: Thymoma: Morphologic subclassification correlates with invasiveness and immunologic features. Histogenetic subclassification correlates with clinical and immunohistochemical features. A study of 122 cases. Hum Pathol 24: 958-969, 1993
23. Rahilly MA, Edwards CW, Crocker J, Murray P: Epithelial cell type, clinical behaviour and AgNOR counts in thymic epithelial tumours. Anal Cell Pathol 3: 203-213, 1991
24. Sato Y, Watanabe S, Mukai K, Kodama T, Upton MP, Goto M, Shimosato Y: An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component. Am J Surg Pathol 10: 862-870, 1986
25. Smith MEF, Cowley GP, Dogan A, Weiss SW, Fisher C: E-cadherin is a differentiation antigen of normal schwann cells and is expressed in epithelioid schwann cell tumours. J Pathol 173: 181A, 1994
26. Sorscher SM, Russack V, Cagle M, Feramisco JR, Green MR: Immunolocalization of E-Cadherin in human head and neck cancer. Arch Pathol Lab Med 119: 82-84, 1995
27. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991
28. Tateyama H, Eimoto T, Tada T, Mizuno T, Inagaki H, Hata A, Sasaki M, Masaoka A: p53 protein expression and p53 gene mutation in thymic epithelial tumors. Am J Clin Pathol 104: 375-381, 1995
29. Verley JM, Hollmann KH: Thymoma. A comparative study of clinical stages, histologic features and survival in 200 cases. Cancer 55: 1074-1086, 1985
30. Yang WI, Efird J, Quinatanilla-Martinez L, Choi N, Harris NL: Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies. Hum Pathol 27: 70-76, 1996